2seventy bio, Inc. - Common Stock
2seventy bio, Inc. - Common Stock
Share · US9013841070 · TSVT (XNAS)
Overview
Analyst Grade Summary
gauge-img
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
4
6
0
0
No Price
n/a
Share Float & Liquidity
Free Float 80,22 %
Shares Float 42,7 M
Shares Outstanding 53,23 M
Company Profile for 2seventy bio, Inc. - Common Stock Share
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
Get up to date insights from finAgent about 2seventy bio, Inc. - Common Stock

Company Data

Name 2seventy bio, Inc. - Common Stock
Company 2seventy bio, Inc.
Symbol TSVT
Website https://www.2seventybio.com
Primary Exchange XNAS NASDAQ
ISIN US9013841070
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO William D. Baird III,
Market Capitalization 266 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address 60 Binney Street, 02142 Cambridge
IPO Date 2021-11-03

ID Changes

Date From To
05.11.2021 TSVTV TSVT

Ticker Symbols

Name Symbol
NASDAQ TSVT
More Shares
Investors who hold 2seventy bio, Inc. - Common Stock also have the following shares in their portfolio:
FID-FSREUSEQETF DL ACC
FID-FSREUSEQETF DL ACC ETF
MITSUBISHI LOGISTICS
MITSUBISHI LOGISTICS Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025